Avoro Capital Advisors LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $6.18 Billion distributed in 33 stocks.
Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $825M, Ascendis Pharma A/S with a value of $813M, Argenx Se with a value of $731M, Madrigal Pharmaceuticals, Inc. with a value of $670M, and Krystal Biotech, Inc. with a value of $492M.
Examining the 13F form we can see an decrease of $681M in the current position value, from $6.86B to 6.18B.
Avoro Capital Advisors LLC is based out at New York, NY
Below you can find more details about Avoro Capital Advisors LLC portfolio as well as his latest detailed transactions.